NASDAQ:EGRX | Market Exclusive

Home Tags NASDAQ:EGRX

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) reported earnings of $0.30 per share missing...

ME Staff - August 9, 2017 0

Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - August 9, 2017 0

Analyst Activity – Royal Bank Of Canada Lowers Its Price Target...

ME Staff - July 27, 2017 0

Analyst Activity – Royal Bank Of Canada Lowers Its Price Target...

ME Staff - July 27, 2017 0

Analyst Activity – Mizuho Lowers Its Price Target On Eagle Pharmaceuticals...

ME Staff - July 27, 2017 0

Here’s What Just Happened With Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)

- July 27, 2017 0

Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - July 26, 2017 0

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Files An 8-K Completion of Acquisition or Disposition...

ME Staff - November 17, 2016 0

Eagle Pharmaceuticals (NASDAQ:EGRX) Files An 8-K Signs Definitive Agreement to Acquire...

ME Staff - November 14, 2016 0

1 2 34Page 4 of 4

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

March 16, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NASDAQ:EGRX

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) reported earnings of $0.30 per share missing...

Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Entry into a Material Definitive...

Analyst Activity – Royal Bank Of Canada Lowers Its Price Target...

Analyst Activity – Royal Bank Of Canada Lowers Its Price Target...

Analyst Activity – Mizuho Lowers Its Price Target On Eagle Pharmaceuticals...

Here’s What Just Happened With Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)

Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Regulation FD Disclosure

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Files An 8-K Completion of Acquisition or Disposition...

Eagle Pharmaceuticals (NASDAQ:EGRX) Files An 8-K Signs Definitive Agreement to Acquire...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY